Impact of the COVID-19 pandemic on the occurrence and outcome of cardiogenic shock complicating acute myocardial infarction

MOTOVSKA, Zuzana, Ota HLINOMAZ, Jan MROZEK, Petr KALA and Jiří JARKOVSKÝ. Impact of the COVID-19 pandemic on the occurrence and outcome of cardiogenic shock complicating acute myocardial infarction. European Journal of Internal Medicine. AMSTERDAM: ELSEVIER, 2023, vol. 115, September 2023, p. 134-136. ISSN 0953-6205. Available from: https://dx.doi.org/10.1016/j.ejim.2023.05.032.

Basic information

• Original name: Impact of the COVID-19 pandemic on the occurrence and outcome of cardiogenic shock complicating acute myocardial infarction
• Authors: MOTOVSKA, Zuzana (203 Czech Republic), Ota HLINOMAZ (203 Czech Republic, belonging to the institution), Jan MROZEK (203 Czech Republic), Petr KALA (203 Czech Republic, belonging to the institution) and Jiří JARKOVSKÝ (203 Czech Republic, belonging to the institution).
• Edition: European Journal of Internal Medicine, AMSTERDAM, ELSEVIER, 2023, 0953-6205.

Other information

• Original language: English
• Type of outcome: Article in a journal
• Field of Study: 30201 Cardiac and Cardiovascular systems
• Country of publisher: Netherlands
• Confidentiality degree: is not subject to a state or trade secret
• WWW: URL
• Impact factor: Impact factor: 8.000 in 2022
• RIV identification code: RIV/00216224:14110/23:00133064
• Organization unit: Faculty of Medicine
• Doi: http://dx.doi.org/10.1016/j.ejim.2023.05.032
• UT WoS: 001073531600001
• Keywords in English: cardiogenic shock; acute myocardial infarction; COVID-19
• Tags: 14110115, 14110132, 14110211, 14119612, rivok
• Tags: International impact, Reviewed

Abstract

SARS-CoV-2 predisposes patients to thrombotic disease due to excessive inflammation, platelet activation, endothelial dysfunction, and stasis. The infection was recognized as an independent risk factor for acute myocardial infarction (AMI), which is considered part of the clinical picture of the COVID-19 disease. Cardiovascular disease increases both the susceptibility to SARS-COV-2 and the risk of death in patients with COVID-19. Among those who died and were COVID PCR-positive, almost one-third (30%) suffered from ischemic heart disease .

Links

• LX22NPO5104, research and development project: Name: Národní institut pro výzkum metabolických a kardiovaskulárních onemocnění (Acronym: CarDia)

Investor: Ministry of Education, Youth and Sports of the CR, 5.1 EXCELES

• NV19-02-00086, research and development project: Name: Duální protidestičková léčba pacientů s akutním infarktem myokardu v kardiogenním šoku - studie DAPT-SHOCK AMI

Investor: Ministry of Health of the CR

• 90249, large research infrastructures: Name: CZECRIN IV